Referring to the letter No: 067 / TPI / 10/2017 dated October 20, 2017 received by Indonesia Exchange on October 24, 2017 regarding the plan of PT. Taisho Pharmaceutical Indonesia Tbk to remove the shares listed in Indonesia Stock Exchange, which the plan of delisting has been conveyed by the Company to Indonesia Bourse, Indonesia Bourse has decided to suspend the Company's trading securities (SQBB and SQBI) in Negotiation Market starting from the first trading session on October 25, 2017 until further notice.

Bourse also appealed to all interested parties to always pay attention to information disclosed by PT. Taisho Pharmaceutical Indonesia Tbk. (W)